Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Dezember 2013 08:30 ET | Quelle: Zogenix

Zogenix Announces FDA Approval of 4 mg SUMAVEL(R) DosePro(R) (sumatriptan injection) Needle-Free Delivery System

SAN DIEGO, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders...
10. Dezember 2013 07:30 ET | Quelle: Raptor Pharmaceutical Inc

Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders

NOVATO, Calif., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has submitted an investigational new drug application (IND) to the U.S. Food and...
10. Dezember 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the initiation of an investigator-sponsored trial of vosaroxin in combination...
10. Dezember 2013 01:46 ET | Quelle: Evotec AG

Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim

HAMBURG, Germany, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...
10. Dezember 2013 01:38 ET | Quelle: MorphoSys AG

MorphoSys Announces Additional Clinical Trial of MOR208

MARTINSRIED / MUNICH, Germany, Dec. 10, 2013 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that the Ohio State University (OSU), Department of...
09. Dezember 2013 17:15 ET | Quelle: Cornerstone Pharmaceuticals, Inc.

Cornerstone Pharmaceuticals Presents Updated Phase I Data for CPI-613 at 2013 American Society of Hematology Annual Meeting

CRANBURY, N.J., Dec. 9, 2013 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced updated results from a Phase...
09. Dezember 2013 13:05 ET | Quelle: MacroGenics, Inc.

MacroGenics Announces Presentation of Pre-Clinical Data on DART(R) Molecule Targeting CD123-Positive Leukemic Stem Cells at 55th Annual Meeting of the American Society of Hematology

ROCKVILLE, Md., Dec. 9, 2013 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based...
09. Dezember 2013 12:09 ET | Quelle: Kosair Children's Hospital

E-cigarettes cause alarming increase in calls to poison control center

LOUISVILLE, KY., Dec. 9, 2013 (GLOBE NEWSWIRE) -- As the debate about electronic cigarette regulation continues with the U.S. Food and Drug Administration (FDA) and device manufacturers, data from one...
09. Dezember 2013 11:00 ET | Quelle: Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals Announces New Phase 2 Results Confirming Immediate, Dose-Dependent and Well-Tolerated Reversal of Anticoagulation Activity of XARELTO(R) (rivaroxaban) With Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Reversal Agent

NEW ORLEANS and SOUTH SAN FRANCISCO, Calif., Dec. 9, 2013 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced additional results of a Phase 2 proof-of-concept study that showed...
09. Dezember 2013 10:56 ET | Quelle: TG Therapeutics, Inc.

TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study

All evaluable CLL patients treated with once daily TGR-1202 at 800 mg exhibited significant nodal reductions with 3 of 4 patients achieving > 50% nodal partial response TGR-1202 appears...

Vorherige Seite

Nächste Seite